Digest Network Come funziona
Network
/
Società
No
Non verificato

Norgine

Di cosa scriviamo

FarmaceuticaFitnessMedicina - VarieSaluteSanità

9 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
05/05/2026
Salute
Fitness
Medicina - Varie
Scienza
Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Fonte
Norgine
Emittente
PR News Wire
1.00
0
Press Release cover image
26/03/2026
Salute
Fitness
Medicina - Varie
Scienza
Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
Fonte
Norgine
Emittente
PR News Wire
1.00
0
Press Release cover image
01/08/2025
Salute
Fitness
Medicina - Varie
Norgine welcomes PBS listing in Australia of IFINWIL® (eflornithine) for patients with high-risk neuroblastoma (HRNB)
Fonte
Norgine
Emittente
PR News Wire
1.00
0
Press Release cover image
08/07/2025
Salute
Fitness
Infanzia
Giovani
Terza età
Medicina - Varie
Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)
Fonte
Norgine
Emittente
PR News Wire
1.00
0
17/04/2025
Farmaceutica
Sanità
Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]
Fonte
Norgine
Emittente
PR News Wire
1.00
0
15/04/2025
Farmaceutica
Sanità
Economia
Norgine strengthens rare disease portfolio with acquisition of Theravia
Fonte
Norgine
Emittente
PR News Wire
1.00
0
Press Release cover image
24/01/2025
Farmaceutica
Sanità
Biologia
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.
Fonte
Norgine
Emittente
PR News Wire
1.00
0
Press Release cover image
07/01/2025
Farmaceutica
Sanità
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
Fonte
Norgine
Emittente
PR News Wire
1.00
0
02/10/2024
Farmaceutica
Sanità
Economia
Management
Organizzazione Aziendale
Norgine Announces Appointment of New CEO Janneke van der Kamp
Fonte
Norgine
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0